Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18313036rdf:typepubmed:Citationlld:pubmed
pubmed-article:18313036lifeskim:mentionsumls-concept:C0001675lld:lifeskim
pubmed-article:18313036lifeskim:mentionsumls-concept:C0007450lld:lifeskim
pubmed-article:18313036lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:18313036lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:18313036lifeskim:mentionsumls-concept:C0598424lld:lifeskim
pubmed-article:18313036lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:18313036lifeskim:mentionsumls-concept:C0062068lld:lifeskim
pubmed-article:18313036lifeskim:mentionsumls-concept:C0667301lld:lifeskim
pubmed-article:18313036pubmed:dateCreated2008-3-24lld:pubmed
pubmed-article:18313036pubmed:abstractTextA ROCK inhibitor Fasudil is widely administered to relieve vasospasm in patients after subarachnoid hemorrhage in Japan. We investigated the difference of Fasudil and Y-27632, a common ROCK inhibitor, on neurite regeneration in culture and axonal regeneration after injuring the optic nerve (OpN) in cats. The optimal dose of Y-27632, determined by counting the number and length of neurites in retinal explants, was found to be 100 microM: the only effect of Fasudil was to promote extension of glial processes. We next examined the effects of Fasudil (10 microM-100 microM) and Y-27632 (10 microM-300 microM) on axonal regeneration in the crushed OpN model in vivo. Immediately after crushing the left OpN, Fasudil or Y-27632 was injected into the vitreous and the crushed site. Injection of 10 microM and 100 microM Y-27632 induced extension of the optic axons beyond the crush site, with the latter dosage giving stronger regeneration. Very few axons passed beyond the crush site in the optic nerve with phosphate-buffered saline injection, and no axons elongated in the OpN with Fasudil injection.lld:pubmed
pubmed-article:18313036pubmed:languageenglld:pubmed
pubmed-article:18313036pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313036pubmed:citationSubsetIMlld:pubmed
pubmed-article:18313036pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313036pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313036pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313036pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313036pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313036pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313036pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313036pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18313036pubmed:statusMEDLINElld:pubmed
pubmed-article:18313036pubmed:monthMarlld:pubmed
pubmed-article:18313036pubmed:issn0006-8993lld:pubmed
pubmed-article:18313036pubmed:authorpubmed-author:WatanabeMasam...lld:pubmed
pubmed-article:18313036pubmed:authorpubmed-author:YoshidaJunJlld:pubmed
pubmed-article:18313036pubmed:authorpubmed-author:SaitoKiyoshiKlld:pubmed
pubmed-article:18313036pubmed:authorpubmed-author:TokitaYoshihi...lld:pubmed
pubmed-article:18313036pubmed:authorpubmed-author:IchikawaMasah...lld:pubmed
pubmed-article:18313036pubmed:authorpubmed-author:SagawaHiroeHlld:pubmed
pubmed-article:18313036pubmed:issnTypePrintlld:pubmed
pubmed-article:18313036pubmed:day27lld:pubmed
pubmed-article:18313036pubmed:volume1201lld:pubmed
pubmed-article:18313036pubmed:ownerNLMlld:pubmed
pubmed-article:18313036pubmed:authorsCompleteYlld:pubmed
pubmed-article:18313036pubmed:pagination23-33lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:meshHeadingpubmed-meshheading:18313036...lld:pubmed
pubmed-article:18313036pubmed:year2008lld:pubmed
pubmed-article:18313036pubmed:articleTitleDifferential effects of two ROCK inhibitors, Fasudil and Y-27632, on optic nerve regeneration in adult cats.lld:pubmed
pubmed-article:18313036pubmed:affiliationDepartment of Neurosurgery, Nagoya University Graduate School of Medicine, Tsuruma-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan.lld:pubmed
pubmed-article:18313036pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18313036pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:18313036pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed